Synergy CHC (SNYR) EBITDA (2014 - 2025)

Synergy CHC (SNYR) posted quarterly EBITDA of -$13.3 million for Q4 2025, down 1139.85% quarter-over-quarter from $1.3 million in Q3 2025.

Synergy CHC (SNYR) EBITDA (2014 - 2025) Analysis & Trends

Synergy CHC's EBITDA history runs 10 years deep, the most recent figure standing at -$13.3 million for Q4 2025.

In Q4 2025, EBITDA changed N/A year-over-year to -$13.3 million; the TTM figure through Dec 2025 stood at -$9.4 million (down 311.72% YoY), while the FY2025 annual figure was -$8.5 million, down 945.87% from the prior year.
EBITDA for Q4 2025 stood at -$13.3 million, down from $1.3 million in the prior quarter.
The five-year high for EBITDA was $4.4 million in Q4 2023, with the low at -$13.3 million in Q4 2025.
The 3-year median for EBITDA is $1.6 million (2024), against an average of $179106.8.
The sharpest annual moves came in 2024 and 2025: EBITDA tumbled 51.1% in 2024, then increased 21.8% in 2025.
Synergy CHC's EBITDA stood at $4.4 million in 2023, then plunged by 76.26% to $1.1 million in 2024, then plunged by 1366.58% to -$13.3 million in 2025.
Business Quant data shows SNYR's EBITDA at -$13.3 million in Q4 2025, $1.3 million in Q3 2025, and $1.6 million in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EBITDA (Qtr)
1	Mckesson	100.02 Bn	94.85 Bn	3.69 Bn	1.32 Bn
2	Cencora	60.88 Bn	58.06 Bn	3.61 Bn	1.27 Bn
3	Cardinal Health	54.14 Bn	49.29 Bn	2.56 Bn	729.00 Mn
4	Henry Schein	10.05 Bn	9.90 Bn	1.10 Bn	171.00 Mn
5	Akso Health	737.16 Mn	736.96 Mn	-	-
6	Edap Tms	159.12 Mn	137.58 Mn	7.34 Mn	-8.03 Mn
7	Accendra Health	100.85 Mn	93.20 Mn	263.41 Mn	-35.15 Mn
8	111	32.10 Mn	-26.65 Mn	18.18 Mn	-2.88 Mn
9	Cosmos Health	12.73 Mn	10.29 Mn	1.51 Mn	-2.81 Mn
10	Synergy CHC	1.12 Mn	-1.67 Mn	2.22 Mn	-13.31 Mn

Download Data